Home » Immusol Changes Name to ItherX, Names New CEO
Immusol Changes Name to ItherX, Names New CEO
Immusol Inc., a privately held biopharmaceutical company, announced that it has changed its name to ItherX Pharmaceuticals Inc. and has appointed Jeffrey F. McKelvy as President, Chief Executive Officer and Director.
BioSpace
BioSpace
Upcoming Events
-
07May
-
14May
-
30May